4951 - 4975 of 8819 Results
Title
Year
-
OPENTitle: A Nigro−Vagal Pathway Controls Gastric Motility and Is Affected in a Rat Model of ParkinsonismJournal Name: GastroenterologyPublisher: Elsevier BVVol: 153Issue #: 6Start Page: 1581End Page: 1593Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1053/j.gastro.2017.08.069Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5705565Citation Count: 97
-
RESTRICTEDTitle: Brain activation pattern related to gait disturbances in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 12Start Page: 1498End Page: 1505Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25139Citation Count: 49
-
RESTRICTEDTitle: Role of serotonin neurons in the induction of levodopa‐ and graft‐induced dyskinesias in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22792Citation Count: 74
-
OPENTitle: Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patientsJournal Name: Toxicology ReportsPublisher: Elsevier BVVol: 4Issue #:Start Page: 188End Page: 193Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.toxrep.2017.03.005Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S221475001730015X-fx1_lrg.jpgCitation Count: 28
-
RESTRICTEDTitle: Mapping the human brain proteome: opportunities, challenges, and clinical potentialJournal Name: Expert Review of ProteomicsPublisher: Informa UK LimitedVol: 21Issue #: 1-3Start Page: 55End Page: 63Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14789450.2024.2313073Citation Count: 3
-
OPENTitle: PREFACE: Divergent roles of ER stress in neurodegeneration and brain disordersJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 527End Page: 529Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.brainres.2016.09.014Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S0006899316306229?via%3DihubCitation Count: 1
-
RESTRICTEDTitle: Sacral nerve stimulation improves gait in Parkinson's diseaseJournal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 4Start Page: 1075End Page: 1076Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2019.03.074Best OA location URL: https://doaj.org/article/1a3d778a5f164f45882a79a2adfcbf97Citation Count: 0
-
OPENTitle: Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson's patientsJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 16Issue #:Start Page: 455End Page: 460Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.08.013Best OA location URL: https://doi.org/10.1016/j.nicl.2017.08.013Citation Count: 33
-
OPENTitle: Genetic analysis of FMR1 repeat expansion in essential tremorJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 593Issue #:Start Page: 114End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2015.03.027Best OA location URL: http://doi.org/10.1016/j.neulet.2015.03.027Citation Count: 13
-
RESTRICTEDTitle: Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 2Start Page: 165End Page: 176Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30391-0Citation Count: 97
-
OPENTitle: RETRACTED: ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In VivoJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 22Issue #: 10Start Page: 1753End Page: 1767Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1038/mt.2014.129Best OA location URL: http://www.cell.com/article/S1525001616307808/pdfCitation Count: 82
-
RESTRICTEDTitle: Reinforcing properties of Pramipexole in normal and parkinsonian ratsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 49Issue #:Start Page: 79End Page: 86Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2012.08.005Best OA location URL: https://doaj.org/article/f2c79dbe00db45cd8b639599d5d6db7fCitation Count: 37
-
OPENTitle: Decreased parvalbumin mRNA expression in dorsolateral prefrontal cortex in Parkinson′s diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1531Issue #:Start Page: 37End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2013.07.025Best OA location URL: http://doi.org/10.1016/j.brainres.2013.07.025Citation Count: 28
-
RESTRICTEDTitle: Structure-based optimization and binding assays for discovery of tau PET radiotracers: synthesis and in vivo evaluation of [11C]Z-3272Journal Name: Canadian Journal of ChemistryPublisher: Canadian Science PublishingVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1139/cjc-2025-0058Best OA location URL: https://doi.org/10.1139/cjc-2025-0058Citation Count: 0
-
RESTRICTEDTitle: AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 10Issue #: 4Start Page: 309End Page: 319Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(11)70039-4Citation Count: 655
-
OPENTitle: A harmonized segmentation protocol for hippocampal and parahippocampal subregions: Why do we need one and what are the key goals?Journal Name: HippocampusPublisher: WileyVol: 27Issue #: 1Start Page: 3End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hipo.22671Best OA location URL: https://archive-ouverte.unige.ch/unige:111733Citation Count: 162
-
OPENTitle: A Large-Scale Multi-ancestry Genome-wide Study Accounting for Smoking Behavior Identifies Multiple Significant Loci for Blood PressureJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 102Issue #: 3Start Page: 375End Page: 400Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ajhg.2018.01.015Best OA location URL: http://www.cell.com/article/S000292971830017X/pdfCitation Count: 153
-
OPENTitle: Isolating Visual and Proprioceptive Components of Motor Sequence Learning in ASDJournal Name: Autism ResearchPublisher: WileyVol: 9Issue #: 5Start Page: 563End Page: 569Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/aur.1537Best OA location URL: http://doi.org/10.1002/aur.1537Citation Count: 34
-
OPENTitle: A data-driven model of disability progression in progressive multiple sclerosisJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcae434Best OA location URL: https://doi.org/10.1093/braincomms/fcae434Citation Count: 1
-
OPENTitle: Olfactory identification in LRRK 2 G2019S mutation carriers: a relevant marker?Journal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 1Issue #: 9Start Page: 670End Page: 678Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.95Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.95Citation Count: 39
-
OPENTitle: Targeting specific kinase substrates rescues increased colitis severity induced by the Crohn’s disease–linked LRRK2-N2081D variantJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 135Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci190017Best OA location URL: https://doi.org/10.1172/jci190017Citation Count: 0
-
OPENTitle: Understanding the Neurobiology of Cd200 and the Cd200 Receptor: A Therapeutic Target For Controlling Inflammation In Human Brains?Journal Name: Future NeurologyPublisher: Informa UK LimitedVol: 8Issue #: 3Start Page: 321End Page: 332Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/fnl.13.14Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3815586Citation Count: 50
-
RESTRICTEDTitle: At last, a randomised controlled trial of apomorphine infusionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 9Start Page: 732End Page: 733Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30284-9Citation Count: 3
-
RESTRICTEDTitle: Characterization of axon guidance cue sensitivity of human embryonic stem cell-derived dopaminergic neuronsJournal Name: Molecular and Cellular NeurosciencePublisher: Elsevier BVVol: 45Issue #: 4Start Page: 324End Page: 334Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.mcn.2010.07.004Citation Count: 23
-
OPENTitle: Acoustic Coordinated Reset Neuromodulation in a Real Life Patient Population with Chronic Tonal TinnitusJournal Name: BioMed Research InternationalPublisher: WileyVol: 2015Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2015/569052Best OA location URL: https://downloads.hindawi.com/journals/bmri/2015/569052.pdfCitation Count: 24